<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39073192</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2796</ISSN><JournalIssue CitedMedium="Internet"><Volume>296</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of internal medicine</Title><ISOAbbreviation>J Intern Med</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 spike protein acts as a &#x3b2;-adrenergic receptor agonist: A potential mechanism for cardiac sequelae of long COVID.</ArticleTitle><Pagination><StartPage>291</StartPage><EndPage>297</EndPage><MedlinePgn>291-297</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/joim.20000</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Currently, pathophysiological mechanisms of post-acute sequelae of coronavirus disease-19-cardiovascular syndrome (PASC-CVS) remain unknown.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Patients with PASC-CVS exhibited significantly higher circulating levels of severe acute respiratory syndrome-coronavirus-2 spike protein S1 than the non-PASC-CVS patients and healthy controls. Moreover, individuals with high plasma spike protein S1 concentrations exhibited elevated heart rates and normalized low frequency, suggesting cardiac &#x3b2;-adrenergic receptor (&#x3b2;-AR) hyperactivity. Microscale thermophoresis (MST) assay revealed that the spike protein bound to &#x3b2;<sub>1</sub>- and &#x3b2;<sub>2</sub>-AR, but not to D1-dopamine receptor. These interactions were blocked by &#x3b2;<sub>1</sub>- and &#x3b2;<sub>2</sub>-AR blockers. Molecular docking and MST assay of &#x3b2;-AR mutants revealed that the spike protein interacted with the extracellular loop 2 of both &#x3b2;-ARs. In cardiomyocytes, spike protein dose-dependently increased the cyclic adenosine monophosphate production with or without epinephrine, indicating its allosteric effects on &#x3b2;-ARs.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Severe acute respiratory syndrome-coronavirus-2 spike proteins act as an allosteric &#x3b2;-AR agonist, leading to cardiac &#x3b2;-AR hyperactivity, thus contributing to PASC-CVS.</AbstractText><CopyrightInformation>&#xa9; 2024 The Association for the Publication of the Journal of Internal Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Xiangning</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Hongtu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haiyi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingjia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenyao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dongyang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Youyi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Erdan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Health and Rehabilitation Sciences, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yida</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Han</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4124-9411</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Health and Rehabilitation Sciences, Qingdao, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021YFF0501401</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2023YFA1800902</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>81830009</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>82030072</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>82070235</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>82300295</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2021-I2M-5-003</GrantID><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country/></Grant><Grant><GrantID>22HHXBSS00007</GrantID><Agency>Haihe Laboratory of Cell Ecosystem Innovation Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Intern Med</MedlineTA><NlmUniqueID>8904841</NlmUniqueID><ISSNLinking>0954-6820</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000318">Adrenergic beta-Agonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000318" MajorTopicYN="N">Adrenergic beta-Agonists</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2 spike protein</Keyword><Keyword MajorTopicYN="N">agonist</Keyword><Keyword MajorTopicYN="N">cardiac sympathetic hyperactivity</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">&#x3b2;&#x2010;adrenergic receptor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39073192</ArticleId><ArticleId IdType="doi">10.1111/joim.20000</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>The Lancet. Long COVID: 3 years in. Lancet. 2023;401:795.</Citation></Reference><Reference><Citation>Writing Committee, Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, et&#xa0;al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID&#x2010;19 in adults: myocarditis and other myocardial involvement, post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;79:1717&#x2013;1756.</Citation></Reference><Reference><Citation>Puntmann VO, Martin S, Shchendrygina A, Hoffmann J, Ka MM, Giokoglu E, et&#xa0;al. Long&#x2010;term cardiac pathology in individuals with mild initial COVID&#x2010;19 illness. Nat Med. 2022;28:2117&#x2013;2123.</Citation></Reference><Reference><Citation>Fedorowski A, Fanciulli A, Raj SR, Sheldon R, Shibao CA, Sutton R. Cardiovascular autonomic dysfunction in post&#x2010;COVID&#x2010;19 syndrome: a major health&#x2010;care burden. Nat Rev Cardiol. 2024;21:379&#x2013;395.</Citation></Reference><Reference><Citation>Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et&#xa0;al. Structure of the SARS&#x2010;CoV&#x2010;2 spike receptor&#x2010;binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;220.</Citation></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas&#x2010;Hill Z, Yu XG, Li, JZ, Alter G, et&#xa0;al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post&#x2010;acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76:e487&#x2013;e490.</Citation></Reference><Reference><Citation>Lael M, Yonker, Z, Swank YC, Burns MD, Kane A, Boribong BP, et&#xa0;al. Circulating spike protein detected in post&#x2010;COVID&#x2010;19 mRNA vaccine myocarditis. Circulation. 2023;147:867&#x2013;876.</Citation></Reference><Reference><Citation>Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:258.</Citation></Reference><Reference><Citation>Xu X, Kaindl J, Clark MJ, H&#xfc;bner H, Hirata K, Sunahara RK, et&#xa0;al. Binding pathway determines norepinephrine selectivity for the human &#x3b2;1&#x2010;AR over &#x3b2;2&#x2010;AR. Cell Res. 2021;31:569&#x2013;579.</Citation></Reference><Reference><Citation>Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC, et&#xa0;al. Adrenaline&#x2010;activated structure of &#x3b2;2 adrenoceptor stabilized by an engineered nanobody. Nature. 2013;502:575&#x2013;579.</Citation></Reference><Reference><Citation>Sun D, Sang Z, Kim YJ, Xiang Y, Cohen T, Belford AK, et&#xa0;al. Potent neutralizing nanobodies resist convergent circulating variants of SARS&#x2010;CoV&#x2010;2 by targeting diverse and conserved epitopes. Nat Commun. 2021;12:4676.</Citation></Reference><Reference><Citation>Pierce BG, Wiehe K, Hwang H, Kim BH, Vreven T, Weng Z. ZDOCK server: interactive docking prediction of protein&#x2010;protein complexes and symmetric multimers. Bioinformatics. 2014;30:1771&#x2013;1773.</Citation></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763.</Citation></Reference><Reference><Citation>West Graham M, Chien Ellen YT, Katritch V, Gatchalian J, Chalmers MJ, Stevens RC, et&#xa0;al. Ligand&#x2010;dependent perturbation of the conformational ensemble for the GPCR &#x3b2;2&#x2010;adrenergic receptor revealed by HDX. Structure. 2011;19:1424&#x2013;1432.</Citation></Reference><Reference><Citation>Chen H, Cao N, Wang L, Wu Y, Wei H, Li Y, et&#xa0;al. Biased activation of &#x3b2;2&#x2010;AR/Gi/GRK2 signal pathway attenuated &#x3b2;1&#x2010;AR sustained activation induced by &#x3b2;1&#x2010;adrenergic receptor autoantibody. Cell Death Discov. 2021;7:340.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>